EXTERNAL VALIDATION OF THE NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) DECOMPENSATION RISK SCORE TO PREDICT HEPATIC EVENTS IN AN ETHNICALLY DIVERSE COHORT

被引：0
|
作者：
Gangasani, Nikitha [1 ]
Ahmed, Heidi [2 ]
Long, Michelle [2 ]
Jayanna, Manju Bengaluru [3 ]
Sanchez, Antonio J. [4 ]
Murali, Arvind R. [5 ]
机构：
[1] Boston Univ, Med Ctr, Internal Med, Boston, MA 02215 USA
[2] Boston Univ, Med Ctr, Gastroenterol, Boston, MA 02215 USA
[3] Univ Iowa, Biostat & Res Design, Inst Clin & Translat Sci, Iowa City, IA 52242 USA
[4] Univ Iowa, Sch Med, Iowa City, IA 52242 USA
[5] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1508
引用
收藏
页码：913A / 914A
页数：2
相关论文
共 50 条
  • [31] Comparison of transient elastography and NAFLD fibrosis score in non-alcoholic fatty liver disease
    Wu, Y.
    Weltman, M.
    Eslick, G. D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 100 - 100
  • [32] The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study
    Motamed, Nima
    Nikkhah, Mehdi
    Niya, Mohammad Hadi Karbalaie
    Khoonsari, Mahmoodreza
    Perumal, Dhayaneethie
    Ashrafi, G. Hossein
    Faraji, Amir Hossein
    Maadi, Mansooreh
    Ajdarkosh, Hossein
    Tameshkel, Fahimeh Safarnezhad
    Moradi-Lakeh, Maziar
    Miri, Seyyed Mohammad
    Arsang-Jang, Shahram
    Zamani, Farhad
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (06)
  • [33] Presumed Non-alcoholic Steatofibrosis Can Independently Predict Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Younossi, Zobair M.
    Stepanova, Maria
    Golabi, Pegah
    Pham, Huong T.
    Cable, Rebecca
    Cooper, James N.
    Rafiq, Nila
    Bush, Haley
    Mann, Puneetinder
    Gogoll, Trevor
    HEPATOLOGY, 2017, 66 : 1143A - 1143A
  • [34] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment
    Bugianesi, E
    Marzocchi, R
    Villanova, N
    Marchesini, G
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1105 - 1116
  • [35] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53
  • [36] Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)
    Golabi, Pegah
    Stepanova, Maria
    Pham, Huong T.
    Cable, Rebecca
    Rafiq, Nila
    Bush, Haley
    Gogoll, Trevor
    Younossi, Zobair M.
    BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01):
  • [37] Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
    Alwahsh, Salamah Mohammad
    Gebhardt, Rolf
    ARCHIVES OF TOXICOLOGY, 2017, 91 (04) : 1545 - 1563
  • [38] Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD)
    Salamah Mohammad Alwahsh
    Rolf Gebhardt
    Archives of Toxicology, 2017, 91 : 1545 - 1563
  • [39] ASSOCIATIONS OF ENHANCED LIVER FIBROSIS SCORE (ELF) WITH HEPATIC COLLAGEN QUANTITATION AND DISEASE ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Younossi, Zobair M.
    Tan, Daisong
    Abdelaal, Hala
    Alaparthi, Lakshmi
    Monge, Fanny
    Myers, Robert P.
    Nader, Fatema
    Goodman, Zachary
    Stepanova, Maria
    HEPATOLOGY, 2021, 74 : 804A - 804A
  • [40] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
12345